Ann Dermatol.  2018 Jun;30(3):382-383. 10.5021/ad.2018.30.3.382.

Treatment of Hair Loss in the Trichorhinophalangeal Syndrome

• Choi MS
• Park MJ
• Park M
• Nam CH
• Hong SP
• Kim MH
• Park BC

• KMID: 2419191
• DOI: http://doi.org/10.5021/ad.2018.30.3.382

Abstract

No abstract available.

MeSH Terms

Hair*

Figure

• 

  Fig. 1 (A) Clinical photo of 17-year-old male with diffuse hair loss, bulbous pear-shaped nose, long philtrum, thin upper vermilion boarder, typical finding of trichorhinophalangeal syndrome. (B) Diffuse hair thinning and regression of frontotemporal hair line shown at the first visit. (C) Hair loss progressed to C3V1 of basic and specific classification and hair growth retardation was found despite of minoxidil treatment.

• 

  Fig. 2 (A) In spite of 2 years of treatment with finasteride (1 mg/d), alopecia has been worsened to U1 type in basic and specific classification and hairs has been thinner and thinner. (B) At 2 years after hair transplantation. Transplanted hair had grown successfully. The frontal hair line had been well maintained.

Reference

1. Ito T, Shimomura Y, Farooq M, Suzuki N, Sakabe J, Tokura Y. Trichorhinophalangeal syndrome with low expression of TRPS1 on epidermal and hair follicle epithelial cells. J Dermatol. 2013; 40:396–398.

2. Yáñez S, Hernández-Vicente I, Armijo M. Trichorhinophalangeal syndrome. Int J Dermatol. 1992; 31:706–709.

3. Lalević-Vasić BM, Nikolić MM, Polić DJ. [Study of hair in type I tricho-rhino-phalangeal syndrome]. Ann Dermatol Venereol. 1994; 121:618–622. French.

4. Seitz CS, Lüdecke HJ, Wagner N, Bröcker EB, Hamm H. Trichorhinophalangeal syndrome type I: clinical and molecular characterization of 3 members of a family and 1 sporadic case. Arch Dermatol. 2001; 137:1437–1442.

5. Chang GT, Jhamai M, van Weerden WM, Jenster G, Brinkmann AO. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer. Endocr Relat Cancer. 2004; 11:815–822.